[(R)-1-(2-Hydroxy-ethyl)-piperidin-3-yl]-carbaMic acid tert-butyl ester
![[(R)-1-(2-Hydroxy-ethyl)-piperidin-3-yl]-carbaMic acid tert-butyl ester price.](/CAS/20120318/GIF/CB72577079.gif)
|
- $243 - $2997
- Product name: [(R)-1-(2-Hydroxy-ethyl)-piperidin-3-yl]-carbaMic acid tert-butyl ester
- CAS: 1354003-20-5
- MF: C12H24N2O3
- MW: 244.33
- EINECS:
- MDL Number:MFCD21094517
- Synonyms:[(R)-1-(2-Hydroxy-ethyl)-piperidin-3-yl]-carbaMic acid tert-butyl ester;Carbamic acid, N-[(3R)-1-(2-hydroxyethyl)-3-piperidinyl]-, 1,1-dimethylethyl ester
10 prices
Selected condition：
Brand
- aablocks
- AK Scientific
- Crysdot
Package
- 50mg
- 100mg
- 250mg
- 500mg
- 1g
- 2.5g
- 5g
- 10g
- Manufactureraablocks
- Product numberAA01F4RQ
- Product description(R)-tert-Butyl (1-(2-hydroxyethyl)piperidin-3-yl)carbamate 95.00%
- Packaging100mg
- Price$342
- Updated2026-05-30
- Buy
- Manufactureraablocks
- Product numberAA01F4RQ
- Product description(R)-tert-Butyl (1-(2-hydroxyethyl)piperidin-3-yl)carbamate 95.00%
- Packaging250mg
- Price$474
- Updated2026-05-30
- Buy
- Manufactureraablocks
- Product numberAA01F4RQ
- Product description(R)-tert-Butyl (1-(2-hydroxyethyl)piperidin-3-yl)carbamate 95.00%
- Packaging500mg
- Price$723
- Updated2026-05-30
- Buy
- Manufactureraablocks
- Product numberAA01F4RQ
- Product description(R)-tert-Butyl (1-(2-hydroxyethyl)piperidin-3-yl)carbamate 95.00%
- Packaging1g
- Price$914
- Updated2026-05-30
- Buy
- Manufactureraablocks
- Product numberAA01F4RQ
- Product description(R)-tert-Butyl (1-(2-hydroxyethyl)piperidin-3-yl)carbamate 95.00%
- Packaging50mg
- Price$243
- Updated2026-05-30
- Buy
- Manufactureraablocks
- Product numberAA01F4RQ
- Product description(R)-tert-Butyl (1-(2-hydroxyethyl)piperidin-3-yl)carbamate 95.00%
- Packaging2.5g
- Price$1753
- Updated2026-05-30
- Buy
- Manufactureraablocks
- Product numberAA01F4RQ
- Product description(R)-tert-Butyl (1-(2-hydroxyethyl)piperidin-3-yl)carbamate 95.00%
- Packaging5g
- Price$2575
- Updated2026-05-30
- Buy
- ManufacturerAK Scientific
- Product number5165DS
- Product description[(R)-1-(2-Hydroxy-ethyl)-piperidin-3-yl]-carbamicacidtert-butylester
- Packaging10g
- Price$2997
- Updated2021-12-16
- Buy
- ManufacturerAK Scientific
- Product number5165DS
- Product description[(R)-1-(2-Hydroxy-ethyl)-piperidin-3-yl]-carbamicacidtert-butylester
- Packaging100mg
- Price$289
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11283574
- Product description(R)-tert-Butyl (1-(2-hydroxyethyl)piperidin-3-yl)carbamate 97%
- Packaging1g
- Price$1499
- Updated2026-05-26
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| aablocks | AA01F4RQ | (R)-tert-Butyl (1-(2-hydroxyethyl)piperidin-3-yl)carbamate 95.00% | 100mg | $342 | 2026-05-30 | Buy |
| aablocks | AA01F4RQ | (R)-tert-Butyl (1-(2-hydroxyethyl)piperidin-3-yl)carbamate 95.00% | 250mg | $474 | 2026-05-30 | Buy |
| aablocks | AA01F4RQ | (R)-tert-Butyl (1-(2-hydroxyethyl)piperidin-3-yl)carbamate 95.00% | 500mg | $723 | 2026-05-30 | Buy |
| aablocks | AA01F4RQ | (R)-tert-Butyl (1-(2-hydroxyethyl)piperidin-3-yl)carbamate 95.00% | 1g | $914 | 2026-05-30 | Buy |
| aablocks | AA01F4RQ | (R)-tert-Butyl (1-(2-hydroxyethyl)piperidin-3-yl)carbamate 95.00% | 50mg | $243 | 2026-05-30 | Buy |
| aablocks | AA01F4RQ | (R)-tert-Butyl (1-(2-hydroxyethyl)piperidin-3-yl)carbamate 95.00% | 2.5g | $1753 | 2026-05-30 | Buy |
| aablocks | AA01F4RQ | (R)-tert-Butyl (1-(2-hydroxyethyl)piperidin-3-yl)carbamate 95.00% | 5g | $2575 | 2026-05-30 | Buy |
| AK Scientific | 5165DS | [(R)-1-(2-Hydroxy-ethyl)-piperidin-3-yl]-carbamicacidtert-butylester | 10g | $2997 | 2021-12-16 | Buy |
| AK Scientific | 5165DS | [(R)-1-(2-Hydroxy-ethyl)-piperidin-3-yl]-carbamicacidtert-butylester | 100mg | $289 | 2021-12-16 | Buy |
| Crysdot | CD11283574 | (R)-tert-Butyl (1-(2-hydroxyethyl)piperidin-3-yl)carbamate 97% | 1g | $1499 | 2026-05-26 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|